Omalizumab Improves Angioedema-Related Quality of Life Impariment in Patients With Chronic Idiopathic Chronic Spontaneous Urticaria: Results from the X-Act Study. J of Skin 2018, 2 (S1), S53. https://doi.org/10.25251/skin.2.supp.53.